Bayer third-quarter earnings beat expectations on pharma

FRANKFURT (Reuters) - Bayer , the German drugmaker that is buying U.S. seed company Monsanto , beat expectations for third-quarter earnings on gains in pharmaceuticals and forecast-beating farming pesticides. Third-quarter profit before interest, taxes, depreciation and amortisation (EBITDA), adjusted for one-off items, rose 6 percent to 2.68 billion euros (2 billion pounds), above the average estimate of 2.52 billion in a Reuters poll among analysts. ...